GIT1 and gastric cancer: miR-122-5p is downregulated in gastric cancer and suppresses gastric tumor proliferation and metastasis by targeting GIT1 [62], suggesting that promoting miR-122-5p function could suppress chronic atrophic gastritis and potentially inhibit the development of gastric cancer.